Shaveta Malik, MD
Obstetrics & Gynecology · Buffalo, NYNPI 1154632966
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (52.6%), consulting fees and education — rather than concentrated in one kind of arrangement. 29 manufacturers reported payments, led by Novo Nordisk at 47.8% of the total. Reporting peaked in 2020 at $2,749 and has fallen 78.7% since, to $585 in 2025. Among obstetrics & gynecology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 143 payments — averaging $39.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$3K
- Astellas Pharma US Inc$322
- Mayne Pharma Commercial LLC$263
- Agile Therapeutics, Inc.$228
- Therapeuticsmd, Inc.$227
- Exeltis, USA Inc.$224
- plus $2K from 23 others
What the payments were for
- Consulting fees$2,64047%
- Food & beverage$2,94453%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 3 | $2,675 |
| Astellas Pharma US Inc | 10 | $322 |
| Mayne Pharma Commercial LLC | 14 | $263 |
| Agile Therapeutics, Inc. | 8 | $228 |
| Therapeuticsmd, Inc. | 9 | $227 |
| Exeltis, USA Inc. | 11 | $224 |
| Pfizer | 10 | $173 |
| Sumitomo Pharma America, Inc. | 7 | $165 |
| Organon | 11 | $165 |
| Coopersurgical, Inc. | 8 | $140 |
| Exact Sciences | 4 | $93 |
| Biogen | 4 | $91 |
| Bayer | 5 | $87 |
| AbbVie | 4 | $81 |
| Medtronic | 3 | $74 |
| Lilly USA, LLC | 4 | $72 |
| Amgen | 4 | $68 |
| Hologic Sales And Service, LLC | 3 | $62 |
| Dexcom, Inc. | 2 | $58 |
| Daiichi Sankyo Inc. | 3 | $52 |
| Mylan Pharmaceuticals Inc. | 3 | $46 |
| Millicent US Inc | 2 | $39 |
| Merck | 2 | $36 |
| Avion Pharmaceuticals | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| Boston Scientific | 1 | $29 |
| Shield Therapeutics Inc | 2 | $28 |
| Bio Products Laboratory USA, Inc. | 1 | $21 |
| AMAG Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NovoSeven RT$2,640
- Veozah$125
- ANNOVERA$123
- IMVEXXY$123
- Twirla$122
How this compares
$5,598 in reported general payments places this provider in the 90th percentile of 2,673 obstetrics & gynecology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 28 | $4,076 |
| Nystatin-TriamcinoloneNystatin/Triamcinolone Acet | 11 | $215 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Buffalo
- Joseph de NagyBuffalo$22K
- Mary PolanNew York$862K
- Steven GoldsteinNew York$551K
- Veronica LernerNew York$368K
- Lisa EngNew York$219K
- Theodore GoldmanEast Northport$213K
- Miriam CremerBrooklyn$196K
- Rachel MaschNew York$187K
- Amy PollackNew York$184K
- Jian Qun HuangNew York$160K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.